huffingtonpost.com
By Jay Scott
3/11/2014

By now, you have heard the story of young Josh Hardy, a 7-year-old childhood cancer survivor who is fighting for his life against a viral infection. A small drug company in North Carolina (Chimerix) has a medication, Brincidofovir, in clinical trial that fights off viral infections similar to Josh's, but have made the choice to refuse access to what may be the only hope to save Josh's life. This has angered people everywhere (including me) and left us to ask the fundamental question - if a drug exists that can save the life of a child, why is that access being denied?

>> Read more